Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein.

Gutwein P, Abdel-Bakky MS, Schramme A, Doberstein K, Kämpfer-Kolb N, Amann K, Hauser IA, Obermüller N, Bartel C, Abdel-Aziz AA, El Sayed el SM, Pfeilschifter J.

Am J Pathol. 2009 Jun;174(6):2061-72. doi: 10.2353/ajpath.2009.080960. Epub 2009 May 12.

2.

The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10.

Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, Broadway N, Hartmann D, Sedlacek R, Dietrich S, Muetze B, Schuster B, Kallen KJ, Saftig P, Rose-John S, Ludwig A.

J Immunol. 2004 May 15;172(10):6362-72.

3.

The role of CXCL16 and its processing metalloproteinases ADAM10 and ADAM17 in the proliferation and migration of human mesangial cells.

Schramme A, Abdel-Bakky MS, Kämpfer-Kolb N, Pfeilschifter J, Gutwein P.

Biochem Biophys Res Commun. 2008 May 30;370(2):311-6. doi: 10.1016/j.bbrc.2008.03.088. Epub 2008 Mar 26.

PMID:
18373975
4.

A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16.

Gough PJ, Garton KJ, Wille PT, Rychlewski M, Dempsey PJ, Raines EW.

J Immunol. 2004 Mar 15;172(6):3678-85.

5.

Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney.

Schramme A, Abdel-Bakky MS, Gutwein P, Obermüller N, Baer PC, Hauser IA, Ludwig A, Gauer S, Schäfer L, Sobkowiak E, Altevogt P, Koziolek M, Kiss E, Gröne HJ, Tikkanen R, Goren I, Radeke H, Pfeilschifter J.

Kidney Int. 2008 Aug;74(3):328-38. doi: 10.1038/ki.2008.181. Epub 2008 May 14.

6.

CXCL16 and oxLDL are induced in the onset of diabetic nephropathy.

Gutwein P, Abdel-Bakky MS, Doberstein K, Schramme A, Beckmann J, Schaefer L, Amann K, Doller A, Kämpfer-Kolb N, Abdel-Aziz AA, El Sayed el SM, Pfeilschifter J.

J Cell Mol Med. 2009 Sep;13(9B):3809-25. doi: 10.1111/j.1582-4934.2009.00761.x. Epub 2009 May 1.

7.

ADAM10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseases.

Gutwein P, Schramme A, Abdel-Bakky MS, Doberstein K, Hauser IA, Ludwig A, Altevogt P, Gauer S, Hillmann A, Weide T, Jespersen C, Eberhardt W, Pfeilschifter J.

J Biomed Sci. 2010 Jan 13;17:3. doi: 10.1186/1423-0127-17-3.

8.

Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.

Gutwein P, Schramme A, Sinke N, Abdel-Bakky MS, Voss B, Obermüller N, Doberstein K, Koziolek M, Fritzsche F, Johannsen M, Jung K, Schaider H, Altevogt P, Ludwig A, Pfeilschifter J, Kristiansen G.

Eur J Cancer. 2009 Feb;45(3):478-89. doi: 10.1016/j.ejca.2008.10.023. Epub 2008 Dec 11.

PMID:
19070478
9.

CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions.

Wuttge DM, Zhou X, Sheikine Y, Wågsäter D, Stemme V, Hedin U, Stemme S, Hansson GK, Sirsjö A.

Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):750-5. Epub 2004 Feb 26.

10.

Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes.

Hundhausen C, Schulte A, Schulz B, Andrzejewski MG, Schwarz N, von Hundelshausen P, Winter U, Paliga K, Reiss K, Saftig P, Weber C, Ludwig A.

J Immunol. 2007 Jun 15;178(12):8064-72.

11.

Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells.

Ludwig A, Schulte A, Schnack C, Hundhausen C, Reiss K, Brodway N, Held-Feindt J, Mentlein R.

J Neurochem. 2005 Jun;93(5):1293-303.

12.

Inhibition of CXCL16 attenuates inflammatory and progressive phases of anti-glomerular basement membrane antibody-associated glomerulonephritis.

Garcia GE, Truong LD, Li P, Zhang P, Johnson RJ, Wilson CB, Feng L.

Am J Pathol. 2007 May;170(5):1485-96.

13.

Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by alpha- and gamma-secretases.

Schulte A, Schulz B, Andrzejewski MG, Hundhausen C, Mletzko S, Achilles J, Reiss K, Paliga K, Weber C, John SR, Ludwig A.

Biochem Biophys Res Commun. 2007 Jun 22;358(1):233-40. Epub 2007 Apr 24.

PMID:
17467666
14.

Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis.

Nanki T, Shimaoka T, Hayashida K, Taniguchi K, Yonehara S, Miyasaka N.

Arthritis Rheum. 2005 Oct;52(10):3004-14.

16.

Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints.

van der Voort R, van Lieshout AW, Toonen LW, Slöetjes AW, van den Berg WB, Figdor CG, Radstake TR, Adema GJ.

Arthritis Rheum. 2005 May;52(5):1381-91.

17.

CXC chemokine ligand 16 in periodontal diseases: expression in diseased tissues and production by cytokine-stimulated human gingival fibroblasts.

Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T.

Clin Exp Immunol. 2007 Jul;149(1):146-54. Epub 2007 Apr 25.

18.

The chemokine and scavenger receptor CXCL16/SR-PSOX is expressed in human vascular smooth muscle cells and is induced by interferon gamma.

Wågsäter D, Olofsson PS, Norgren L, Stenberg B, Sirsjö A.

Biochem Biophys Res Commun. 2004 Dec 24;325(4):1187-93.

PMID:
15555552
19.

Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin.

Scholz F, Schulte A, Adamski F, Hundhausen C, Mittag J, Schwarz A, Kruse ML, Proksch E, Ludwig A.

J Invest Dermatol. 2007 Jun;127(6):1444-55. Epub 2007 Mar 15.

20.

oxLDL-induced lipid accumulation in glomerular podocytes: role of IFN-γ, CXCL16, and ADAM10.

Wang L, Sun S, Zhou A, Yao X, Wang Y.

Cell Biochem Biophys. 2014 Sep;70(1):529-38. doi: 10.1007/s12013-014-9952-1.

PMID:
24752304
Items per page

Supplemental Content

Write to the Help Desk